… AKT, mTOR, NF-κB [22], or HIF-1α [23], ultimately leading to … considering the cross-talk
with other signaling pathways, such … In addition to the Wnt/β-catenin, Hedgehog, PI3K/Akt/mTOR, …

… It displays crosstalk with many oncogenic signaling pathways … T cells, GITR signaling is
mediated by activation of NF-κB … in CC cells by modulating EMT via Wnt/β-catenin signaling [ 49 ]. …

… cell line HepG2 is mediated via NF-κB/p53 signaling pathway. … Suppression of the Wnt/β-catenin
pathway by inhibiting the … therapy due to its ability to sensitize cells resistant to erlotinib …

… other complex crosstalk between Wnt/β-catenin signalling … mice treated with 1,25(OH) 2 D3
and erlotinib. These data … FGFBP-1 expression is affected by calcitriol via the NF-κB pathway (…

… The SUMO pathway undergoes constant cross talk with other post-translational … NF-κB
essential modifier (NEMO) [113]. Furthermore, SUMOylation regulates activation of Wnt/β-catenin …

… Wnt/β-catenin pathway The last major pathway … the Wnt/β-catenin pathway (is a subject of
my thesis). As with all signal transduction mechanisms, the major receptors of this pathway are …

… with the EGFR inhibitor Erlotinib showed additional benefits, … Wnt Pathway and the nuclear
factor-kappa B (NF-κB) pathway … Wnt/β-catenin genes in TNBC cells. The direct link between …

… and canonical Wnt/β-catenin signaling pathway regulation in … potential point of cross-talk
between these two pathways and its … Wnt/β-catenin, NF-κB, and Notch signaling are associated …

… -1 and heme, which is crucial for nerve-cancer cell cross-talk. … by p50 NF-κB–CSF-R1–C3aR
axis. This promotes more HO-… cell chemoresistance to anti-cancer reagents erlotinib and …

… erlotinib synergistically decreased cell viability and induced … apoptosis in cancer cells through
decreasing NF-κB activation [84]… activity of the progesterone receptor as established by the …